The historical rank and industry rank for OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
FRA:Q8T'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.75 Med: 19.19 Max: 56.81
Current: 28.25
During the past 6 years, the highest Earnings Yield (Joel Greenblatt) of OrbusNeich Medical Group Holdings was 56.81%. The lowest was 0.75%. And the median was 19.19%.
FRA:Q8T's Earnings Yield (Joel Greenblatt) % is ranked better than 97.69% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 0.285
vs FRA:Q8T: 28.25
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. OrbusNeich Medical Group Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2024 was 23.06%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
OrbusNeich Medical Group Holdings Earnings Yield (Joel Greenblatt) % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
OrbusNeich Medical Group Holdings Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) %
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) % falls into.
OrbusNeich Medical Group Holdings Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
OrbusNeich Medical Group Holdings (FRA:Q8T) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
OrbusNeich Medical Group Holdings Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:Q8T has been successfully added to your 